The Full Story
MYOPIA MANAGEMENT
We offer Myopia Management preventative care as early as 5 years old, and now also offer MiSight® 1 day contact lens (the only FDA approved*soft contact lens indicated to slow the progression of myopia in children ages 8-12 years old at the initiation of treatment
What is MiSight?
MiSight ® 1 Day is a daily wear, single use contact lens that has been clinically proven and FDA- approved to slow the progression of myopia (nearsightedness).
The treatment helps slow the elongation of the eye and myopia progression, while fullycorrecting refractive error.
Addressing axial elongation helps to reduce the risk of myopia-related vision complications later in life, including irreversible vision loss.
Safety and Effectiveness of
MiSight Contact Lenses
The safety and effectiveness of MiSight were studied in a 3-year clinical trial of 135 children aged 8 to 12 who were prescribed either MiSight or traditional soft contact lenses.
Over the 3-year period, myopia progressed at a much slower rate — by 59% to be exact — in the children who wore MiSight contact lenses compared to the children who wore conventional soft contacts.
These results indicate that MiSight could be an excellent option for slowing myopia progression in your child.
Speak with Our Myopia Management Experts to learn more about MiSight contact lenses and to find out how they can help your child effectively limit myopia progression.
